Logo

Prostate Cancer

News and reporting on prostate cancer.

MiraDx Validates Prostate Cancer Radiation Toxicity Prediction Assay in Study
Premium

The company's Prostox germline microRNA-based assay predicted late-onset toxicity following radiation therapy and helped to identify biological pathways involved. 

Novigenix Wins €1.8M EU Grant to Work With Cancer Biomarker Consortium

The Swiss cancer liquid biopsy firm will contribute its expertise and technologies including its AI-driven LITOSeek liquid biopsy platform.

Korea's IMBDx Explores NSCLC Therapy Guidance, Multi-Cancer Early Detection for Liquid Biopsy Tech
Premium

The company recently published data on its NGS-based pleural effusion liquid biopsy panel and is launching a large multimodal MCED study in Korea. 

MDxHealth Q4 Revenues Rise 28 Percent

The firm's full-year 2024 revenues also rose 28 percent to $90.0 million, beating the Wall Street consensus estimate.

Lynx Dx Adds Home-Based Sample Collection in Bid to Expand Reach of its Prostate Cancer MDx
Premium

The firm said that its MyProstateScore 2.0 test delivers equivalent performance with samples collected at home or collected following digital rectal examination.

Feb 25, 2025

Veracyte Eyes Dropping IVD/Pharma Subsidiary in Europe As Growth Concentrates Among Clinical LDTs
Premium

Feb 24, 2025

Myriad Genetics Exclusively Licenses Pathomiq Prostate Cancer Image Analysis Technology in US

Feb 12, 2025

Craig-Hallum Initiates Coverage of Myriad Genetics With a Buy Rating

Feb 5, 2025

Lumea to Incorporate Myriad Genetics Cancer Tests Into Digital Pathology Platform

Jan 28, 2025

Ireland's OncoAssure Eyes US Market With 'Master Driver' Prostate Cancer Prognostic Test
Premium

Dec 20, 2024

VA Launches Prostate Cancer Screening Study to Improve Early Detection, Personalize Recommendations
Premium

Dec 6, 2024

Updated NCCN Guidelines Adjust Ratings for Prostate Cancer Genetic Tests

Nov 7, 2024

NCCN Adds Prostate Cancer to Genetic Risk Assessment Guidelines

Nov 7, 2024

Veracyte Further Cements Data on Core Prostate Test as Q3 Revenues Climb 29 Percent
Premium

Oct 29, 2024

New Cancer Susceptibility Genes Identified in Germline Genetic Variation Study

Oct 25, 2024

Trinity Biotech Acquiring Prostate Cancer Test Developer EpiCapture for at Least $3M

Oct 16, 2024

UBS Initiates Coverage of Veracyte With Buy Rating

Oct 3, 2024

Researchers Stress Specificity of Grail Multi-Cancer Detection Test in Response to Study Criticism
Premium

Sep 30, 2024

Novigenix Developing Liquid Biopsy Test to Guide Treatment of Aggressive Prostate Cancer
Premium

Sep 25, 2024

Kairos Pharma, PreCheck Health Services to Develop CDx for Prostate, Lung Cancer Drug

Sep 24, 2024

Phosphoproteomic Studies Point to Subtypes, Treatment Targets for Gastric, Prostate Cancer

Sep 24, 2024

Novigenix to Develop Prostate Cancer Liquid Biopsy Test With €1.8M Eurostars Consortium Grant

Sep 3, 2024

Foundation Medicine Nets FDA Approval for Tissue, Liquid NGS CDx for Lynparza Combo

Aug 8, 2024

Local Coverage Determinations Roundup: Veracyte

Aug 7, 2024

Veracyte Q2 Revenues up 27 Percent on Prostate, Thyroid Tests; Firm Raises Full-Year Guidance